Home > Assessment of the implementation of the EU Drugs Strategy 2005—2012 and its Action Plans.

Culley, Deirdre May and Skoupy, Jiri and Rubin, Jennifer and Hoorens, Stijn and Disley, Emma and Rabinovich, Lila (2012) Assessment of the implementation of the EU Drugs Strategy 2005—2012 and its Action Plans. Santa Monica, CA.: Rand Europe.

[img] PDF (Rand report) - Published Version
1MB

As the Strategy comes to an end in 2012 and a decision will need to be taken about its successor, the European Commission commissioned an evaluation of the Strategy and its Action Plans (2005–2008 and 2009–2012). This evaluation focuses on the added value of these documents for drugs policy in Member States and third countries. As the competencies for drugs policy (including its public health, criminal justice, enforcement, and customs components) remain primarily at Member State level, the EU Drugs Strategy is expected to add value over national drugs strategies. Therefore, we provide an assessment of the relevance and influence of the current Strategy and the implementation of the Action Plans in Member States and at EU level. This summary first sets out our study’s main findings: first overall findings about the Strategy as a document and a process; second, across each of the two policy areas, demand reduction and supply reduction; and third, across the three cross-cutting themes of the Strategy, coordination; international cooperation; and information, research and evaluation. Finally, the summary provides a brief overview of the evaluation questions and responses arrived at in the course of the study.


Repository Staff Only: item control page